参考文献/References:
[1] 中华医学会糖尿病学分会.中国2型糖尿病防治指南(2017年版)[J].中华糖尿病杂志,2018,10(1): 4-67.
[2] LI Y,TENG D,SHI X,et al.Prevalence of diabetes recorded in mainland China using 2018 diagnostic criteria from the American Diabetes Association: national cross sectional study[J/OL].[2022-03-09].https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7186854/.DOI:10.1136/bmj.m997.
[3] 中华人民共和国中央人民政府.关于做好2020年基本公共卫生服务项目工作的通知[EB/OL].[2021-11-19].http://www.gov.cn/zhengce/zhengceku/2020-06/16/content_5519776.htm.
[4] International Diabetes Federation.IDF call for a multisectoral response to diabetes[EB/OL]. [2021-11-19].https://www.diabetesatlas.org/en/sections/need-for-a-multisectoral-response.html.
[5] CHIOU SJ,LIAO K M,HUANG Y T,et al.Synergy between the pay-for-performance scheme and better physician-patient relationship might reduce the risk of retinopathy in patients with type 2 diabetes[J].J Diabetes Investig,2021,12(5):819-827.
[6] KANTAREVIC J,KRALJ B.Link between pay for performance incentives and physician payment mechanisms:evidence from the diabetes management incentive in Ontario[J].Health Econ,2013,22(12):1417-1439.
[7] CHIEN A T,EASTMAN D,LI Z,et al.Impact of a pay for performance program to improve diabetes care in the safety net[J].Prev Med,2012,55(Suppl):S80-S85.
[8] 杨巧,陈登菊,张伟,等.美、英医保按绩效支付方式对我国的启示[J].中国卫生质量管理,2018,25(2):128-130,133.
[9] 张晓燕,张传政,赵列宾,等.按绩效付费模式(P4P)在优化糖尿病管理中的应用[J].中国卫生资源,2014,17(5):351-354.
[10]陈亚玲,孙子林.糖尿病健康管理支付模式探讨[J].中华糖尿病杂志,2017,9(5):277-280.
[11]谢春艳,何江江,胡善联.英国初级卫生保健质量与结果框架解析[J].中国医院管理,2015,35(7):78-80.
[12]National Health Service Digital.Quality and outcomes framework,2019-20[EB/OL].[2022-03-19].https://digital.nhs.uk/data-and-information/publications/statistical/quality-and-outcomes-framework-achievement-prevalence-and-exceptions-data/2019-20.
[13]Services Australia.Practice incentives program[EB/OL].[2022-03-19].https://www.servicesaustralia.gov.au/organisations/health-professionals/services/medicare/practice-incentives-program.
[14]LEE T,CHENG S,CHEN C,et al.A pay-for-performance program for diabetes care in Taiwan:a preliminary assessment[J].Am J Manag Care,2010,16(1):65-69.
[15]LATHAM L P M,MARSHALL E G P.Performance-based financial incentives for diabetes care: an effective strategy?[J].Can J Diabetes,2015,39(1):83-87.
[16]MARSHALL M,ROLAND M.The future of the quality and outcomes framework in England[J/OL].[2022-03-20].https://www.bmj.com/content/359/bmj.j4681.full.DOI:10.1136/bmj.j4681.
[17]王思敏,徐伟,崔子丹,等.美国加利福尼亚州以价值为本的按绩效付费项目及其对我国全科医生绩效考核体系和激励机制的启示[J].中国全科医学,2019,22(13):1522-1527.
[18]CHEN T T,OLDENBURG B,HSUEH Y S.Chronic care model in the diabetes pay-for-performance program in Taiwan:benefits,challenges and future directions[J].World J Diabetes,2021,12(5):578-589.
[19]Services Australia.Who can get it[EB/OL].[2022-03-19].https://www.servicesaustralia.gov.au/organisations/health-professionals/services/medicare/practice-incentives-program/who-can-get-it.
[20]Services Australia.Practice accreditation[EB/OL].[2022-03-19].https://www.servicesaustralia.gov.au/organisations/health-professionals/services/medicare/practice-incentives-program/who-can-get-it/practice-accreditation.
[21]卫生福利部中央健康保险署.全民健康保险糖尿病医疗给付改善方案[EB/OL].[2022-03-19].https://www.nhi.gov.tw/Resource/webdata/19248_2_糖尿病医疗给付改善方案pdf.
[22]American Diabetes Association.Standards of medical care in diabetes-2020[J].Diabetes Care,2020,43(Suppl 1):S1-S212.
[23]LI Y,ZHAO L,YU D,et al.The prevalence and risk factors of dyslipidemia in different diabetic progression stages among middle-aged and elderly populations in China[J/OL].[2022-03-09].https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6191112/.DOI:10.1371/journal.pone.0205709.
[24]Primary Care Strategy and NHS Contracts Group.2019/20 General Medical Services(GMS)contract quality and outcomes framework[EB/OL].[2022-03-19].https://www.england.nhs.uk/wp-content/uploads/2019/05/gms-contract-qof-guidance-april-2019.pdf.
[25]Services Australia.Practice incentives program diabetes incentive guidelines[EB/OL].[2022-03-19].https://www.servicesaustralia.gov.au/sites/default/files/documents/diabetes-pip-guidelines.docx.
[26]Diabates UK.Position statement:the future of the quality and outcomes framework in England February[EB/OL].[2022-03-19].https://www.diabetes.org.uk/professionals/position-statements-reports/quality-outcomes-framework-england.
[27]耿明菲,刘庆,耿剑平.分级诊疗制度下基层医疗卫生机构2型糖尿病患者健康管理绩效评价指标体系的建立[J].临床医学研究与实践,2019,4(25):177-179.
[28]AALAA M,SANJARI M,SHAHBAZI S,et al.Diabetic foot workshop:improving technical and educational skills for nurses[J/OL].[2022-03-09].https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5473009/.DOI:10.18869/mjiri.31.8.
[29]POWERS M A,BARDSLEY J,CYPRESS M,et al.Diabetes self-management education and support in type 2 diabetes: a joint position statement of the American diabetes association,the American association of diabetes educators,and the academy of nutrition and dietetics[J].Diabetes Care,2015,38(7):1372-1382.
[30]孙辉,王海银,谢春艳,等.美国以价值为导向的医保支付模式应用及启示[J].卫生经济研究,2020,37(6):24-27.
[31]British Medical Association.GP contract England 2020/21[EB/OL].[2022-03-19].https://www.bma.org.uk/pay-and-contracts/contracts/gp-contract/gp-contract-england-202021.
[32]CHEN Y C,LEE C T C,LIN B J,et al.Impact of pay-for-performance on mortality in diabetes patients in Taiwan:a population-based study[J/OL].[2022-03-09].https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5058873/.DOI:10.1097/MD.0000000000004197.
[33]国家卫生健康委员会基层卫生健康司.国家基本公共卫生服务项目管理平台[EB/OL].[2022-03-19].http://www.nbphsp.org.cn/.
[34]黄萍.上海和台湾糖尿病防治管理服务模式对比研究[J].中国全科医学,2018,21(26):3201-3205.
[35]O'CONNOR R,O'DRISCOLL R,O'DOHERTY J,et al.The effect of ‘paying for performance' on the management of type 2 diabetes mellitus:a cross-sectional observational study[J/OL].[2022-03-09]. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7330226/.DOI:10.3399/bjgpopen20X101021.
[36]MARKOVITZ A A,RYAN A M.Pay-for-Performance:disappointing results or masked heterogeneity? [J].Med Care Res Rev,2017,74(1):3-78.
[37]HSIEH H,TSAI S,SHIN S,et al.Cost-effectiveness of diabetes pay-for-performance incentive designs[J].Medical care,2015,53(2):106-115.
[38]CHEN T T,OLDENBURG B,HSUEH Y S.Chronic care model in the diabetes pay-for-performance program in Taiwan: benefits [J].Challenges and Future Directions,2021,12(5):578-589.
[39]HASSAN S N,SADEK A R,TAHIR A,et al.Evaluating tools to support a new practical classification of diabetes: excellent control may represent misdiagnosis and omission from disease registers is associated with worse control[J]. Int J Clin Pract,2012,66(9):874-882.
[40]GUPTA N,AYLES H M.Effects of pay-for-performance for primary care physicians on diabetes outcomes in single-payer health systems:a systematic review[J].Eur J Health Econ,2019,20(9):1303-1315.
[41]BERDAH C T,EASTERLIN M C,RYAN G,et al.Primary care physicians in the merit-based incentive payment system(MIPS):a qualitative investigation of participants' experiences,self-reported practice changes,and suggestions for program administrators[J].J Gen Intern Med,2019,34(10):2275-2281.
相似文献/References:
[1]李高鹏,黄惠桥,梁榕,等.微信群中糖尿病知识动员模型的研究[J].军事护理,2021,38(08):42.[doi:10.3969/j.issn.1008-9993.2021.08.012]
LI Gaopeng,HUANG Huiqiao,LIANG Rong,et al.Diabetes Knowledge Mobilization Model in WeChat Group[J].Nursing Journal Of Chinese People's Laberation Army,2021,38(12):42.[doi:10.3969/j.issn.1008-9993.2021.08.012]
[2]周胜蓝,王雨,温敬冬,等.老年糖尿病膀胱过度活动症患者疾病感知现状及其与生活质量的相关性[J].军事护理,2022,39(01):13.[doi:10.3969/j.issn.1008-9993.2022.01.004]
ZHOU Shenglan,WANG Yu,WEN Jingdong,et al.Status of Disease Perception in Elderly Diabetic Patients with Overactive Bladder and Its Correlation with the Quality of Life[J].Nursing Journal Of Chinese People's Laberation Army,2022,39(12):13.[doi:10.3969/j.issn.1008-9993.2022.01.004]
[3]钱艳,何英姿,朱玮,等.老年糖尿病患者健康信念、慢病资源利用与自我管理行为的关系研究[J].军事护理,2022,39(12):58.[doi:10.3969/j.issn.2097-1826.2022.12.015]
QIAN Yan,HE Yingzi,ZHU Wei,et al.Relationship Between Health Beliefs,Chronic Illness Resource Utilization and Self-management Behavior in Elderly Diabetic Patients[J].Nursing Journal Of Chinese People's Laberation Army,2022,39(12):58.[doi:10.3969/j.issn.2097-1826.2022.12.015]